News + Filings Transactions
|
Turtle Cameron
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 9.5k | $17.00 | $161k | | 01/26/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 53.2k | $13.20 | $701.7k | | 01/26/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Other | Common Stock | 50.7k | $0.00 | $0 | | 01/26/2021 |
| 12/28/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 10.9k | $69.34 | $758.3k | | 12/28/2020 |
| 12/28/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 8.6k | $69.94 | $598.9k | | 12/28/2020 |
| 12/28/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 7.5k | $17.00 | $127.5k | | 12/28/2020 |
| 12/28/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 6k | $0.34 | $2k | | 12/28/2020 |
| 12/28/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 6k | $0.16 | $960 | | 12/28/2020 |
| 12/15/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3.8k | $110.29 | $414.3k | | 12/15/2020 |
| 12/15/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 7.6k | $111.31 | $845.9k | | 12/15/2020 |
| 12/15/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 11.4k | $112.19 | $1.3M | | 12/15/2020 |
| 12/15/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3.5k | $112.97 | $394.6k | | 12/15/2020 |
| 12/15/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 4.5k | $17.00 | $75.7k | | 12/15/2020 |
| 12/15/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 21.8k | $13.20 | $288.3k | | 12/15/2020 |
| 11/25/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 742 | $47.23 | $35k | | 11/24/2020 |
| 11/25/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 742 | $17.00 | $12.6k | | 11/24/2020 |
| 11/24/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 4.3k | $17.00 | $72.4k | | 11/24/2020 |
| 11/24/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 4.3k | $47.00 | $200.1k | | 11/24/2020 |
| 11/11/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3k | $73.56 | $221.1k | | 11/11/2020 |
| 11/11/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 9.5k | $74.75 | $709.9k | | 11/11/2020 |
| 11/11/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 908 | $75.23 | $68.3k | | 11/11/2020 |
| 11/11/2020 | Eidos Therapeutics, Inc. | EIDX | Gift | Common Stock | 1.5k | $0.00 | $0 | | 11/11/2020 |
| 11/05/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 2.5k | $42.05 | $105.1k | | 11/05/2020 |
| 11/05/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 2.5k | $17.00 | $42.5k | | 11/05/2020 |
| 11/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 9.1k | $70.44 | $644.2k | | 11/02/2020 |
| 11/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3.1k | $71.42 | $224.7k | | 11/02/2020 |
| 11/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 209 | $72.10 | $15.1k | | 11/02/2020 |
| 11/02/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 5k | $13.20 | $66k | | 11/02/2020 |
| 11/02/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 2.5k | $17.00 | $42.5k | | 11/02/2020 |
| 09/30/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 6k | $0.16 | $960 | | 09/30/2020 |
| 09/30/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 6k | $0.34 | $2k | | 09/30/2020 |
| 09/30/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 12.4k | $37.59 | $467.8k | | 09/30/2020 |
| 09/30/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 2.1k | $38.24 | $78.7k | | 09/30/2020 |
| 09/30/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Stock Option (Right to Buy) | 2.5k | $17.00 | $42.5k | | 09/30/2020 |
| 09/18/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 2.5k | $42.01 | $105k | | 09/18/2020 |
|
|